Compare COGT & CHEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COGT | CHEF |
|---|---|---|
| Founded | 2014 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.7B |
| IPO Year | 2018 | 2011 |
| Metric | COGT | CHEF |
|---|---|---|
| Price | $31.31 | $110.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | $55.82 | ★ $124.00 |
| AVG Volume (30 Days) | ★ 2.1M | 510.4K |
| Earning Date | 11-02-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 27.27 |
| EPS | N/A | ★ 0.40 |
| Revenue | $7,871,000.00 | ★ $1,301,520,000.00 |
| Revenue This Year | N/A | $10.48 |
| Revenue Next Year | $4,637.35 | $8.61 |
| P/E Ratio | ★ N/A | $279.83 |
| Revenue Growth | N/A | ★ 9.11 |
| 52 Week Low | $13.79 | $56.46 |
| 52 Week High | $43.73 | $118.51 |
| Indicator | COGT | CHEF |
|---|---|---|
| Relative Strength Index (RSI) | 42.35 | 51.05 |
| Support Level | N/A | $105.45 |
| Resistance Level | $37.69 | $116.86 |
| Average True Range (ATR) | 1.19 | 3.95 |
| MACD | 0.08 | 0.04 |
| Stochastic Oscillator | 47.47 | 40.93 |
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States, the Middle East and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.